Evolution Wealth Advisors, LLC Myovant Sciences Ltd. Transaction History

Evolution Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$14.31 - $23.87 $4,121 - $6,874	-288 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$18.94 - $26.99 $8,314 - $11,848	-439 Reduced 60.39%	288 $6,000
Q2 2021 Jul 22, 2021	SELL	$17.07 - $24.56 $2.38 Million - $3.43 Million	-139,500 Reduced 99.48%	727 $17,000
Q4 2020 Feb 02, 2021	BUY	$13.8 - $27.62 $945,520 - $1.89 Million	68,516 Added 95.54%	140,227 $3.87 Million
Q3 2020 Oct 15, 2020	BUY	$14.05 - $22.6 $996,636 - $1.6 Million	70,935 Added 9141.11%	71,711 $1.01 Million
Q2 2020 Jul 27, 2020	SELL	$7.34 - $20.84 $2,422 - $6,877	-330 Reduced 29.84%	776 $16,000
Q1 2020 Apr 22, 2020	BUY	$6.55 - $14.76 $1,310 - $2,952	200 Added 22.08%	1,106 $8,000
Q4 2019 Feb 03, 2020	BUY	$4.2 - $19.21 $3,347 - $15,310	797 Added 731.19%	906 $14,000
Q3 2019 Nov 12, 2019	SELL	$5.19 - $9.46 $2,605 - $4,748	-502 Reduced 82.16%	109 $1,000
Q2 2019 Jul 12, 2019	BUY	$8.69 - $25.0 $5,309 - $15,275	611 New	611 $6,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.